Otsuka Holdings Co. Ltd. said profit for the quarter ended March 31 rose 8.2% year over year, while revenue increased 5.2%.
Profit attributable to owners of the company was about ¥22.73 billion for the period, up from about ¥21.01 billion in the previous year.
The Tokyo-based company's diluted EPS for the first quarter was ¥41.24, compared to ¥38.52 in 2017.
Consolidated revenue for the quarter reached ¥294.65 billion, up from about ¥280.19 billion a year ago.
Otsuka said revenue from its pharmaceutical and nutraceutical segments grew 5% and 7.6%, respectively, year over year. Revenue from the company's consumer products business decreased 0.9%, while its "others" segment — chemicals, warehousing, transportation, direct sales support and insurance — saw a 4.7% drop in revenue.
For the full year ending Dec. 31, Otsuka expects profit attributable to owners to fall 6.7% to ¥105 billion. Revenue is expected to increase 4.8% to ¥1.3 trillion.
As of May 10, US$1 was equivalent to ¥109.58.